Skip to main content
NIH funding notice PA-18-695

Basic and Translational Oral Health Research Related to HIV/AIDS (R21 Clinical Trial Not Allowed)

Closed on January 7, 2021.

Posted
March 5, 2018
Close date
January 7, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $240,550 in first-year total cost, median $240,550.

Most frequent study sections

  1. HIV Comorbidities and Clinical Studies Study Section[HCCS]1

Most frequent institutions

  1. COLORADO STATE UNIVERSITY1
Competing awards under PA-18-695 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Impacts of antiretroviral therapy on oral cavity homeostasis in an FIV animal model1R21DE029733-01A1VANDEWOUDE, SUECOLORADO STATE UNIVERSITY, CO$240,550HCCS

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PA-18-695: Basic and Translational Oral Health Research Related to HIV/AIDS (R21 Clinical Trial Not Allowed) | ScienceDex | ConductScience